Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 234, Issue 8, 1996, Pages 496-503

  Geoff Williams, R ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA DETACHMENT; VITRECTOMY; VITREORETINOPATHY;

EID: 0029786812     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00184858     Document Type: Article

References (2)

1. Berman DH, Gombos GM (1989) Proliferative vitreoretinopathy: does lowdose colchicine have an inhibitory effect? A controlled study in humans. Ophthalmic Surg 20: 268-272
2. Blankenship GW (1991) Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications. Graefe's Arch Clin Exp Ophthalmol 229: 62-65